Nasdaq
XERS
Xeris Biopharma Holdings, Inc.
- Health Care
- Listed 2018
- 1 day
- −9.2%
- 1 month
- −17.7%
- 1 year
- +34.1%
$7.36 · Mkt cap $1.27B
At the 6 Aug 2026 close
Nasdaq
Xeris Biopharma Holdings, Inc.
$7.36 · Mkt cap $1.27B
At the 6 Aug 2026 close
Xeris Biopharma Holdings, Inc. trades under the ticker XERS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2018. Its market capitalisation is $1.27B. The last closing price was $7.36, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +34.1%, and −17.7% over the past month. Returns are price returns and exclude dividends.
This page exists because XERS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.